← 홈

HER2

249개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 249개
ADCBiologicstaleDaiichi SankyoPhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzumab deruxtecan-nxki)

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 71.7%임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Trastuzumab plus chemotherapy)

HER2-positive Breast Cancer; Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab+Nivolumab+Gemcitabine+Cisplatin)

HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab, Pertuzumab, Paclitaxel, or a combination of these drugs)

Metastatic Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab-rezetecan + Pertuzumab + Iparomlimab and Tuvonralimab for HER2 Moderate/Low BTC)

Biliary Tract Cancer (BTC); First-line Therapy · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab-rezetecan + Pertuzumab + Iparomlimab and Tuvonralimab for HER2 Overexpression BTC)

Biliary Tract Cancer (BTC); First-line Therapy · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Trastuzumab-rezetecan Treatment Group)

Trastuzumab-rezetecan; HER2-low Breast Cancer · HER2

#HER2#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleChia Tai Tianqing Pharmaceutica…Phase 3

Trifluridine /Tipiracil (TAS-102, Trifluridine /Tipiracil, Trifluridine /Tipiracil (TAS-102) tablets / Fruquintinib / Regorafenib tablets)

HER2 IHC3+ Advanced Colorectal Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

trastuzumab (Herceptin, Trilaciclib with or without trastuzumab + pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleXencor, Inc.Phase 1

XmAb®23104 (XmAb®23104)

Melanoma (Excluding Uveal Melanoma); Cervical Carcinoma · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 1

ipilimumab (Yervoy®, Yervoy® (ipilimumab))

Melanoma (Excluding Uveal Melanoma); Cervical Carcinoma · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1b)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1c)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleJules Bordet InstitutePhase 1

trastuzumab (Herceptin, Zr89-trastuzumab)

Breast Neoplasms; Secondary · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
효능 ORR 10%임상시험 1상태 ACTIVE
ADCBiologicstaleVanderbilt-Ingram Cancer CenterPhase 1

[68Ga]Ga-ABY-025 ([68Ga]Ga-ABY-025)

Locally Advanced Cancer; Metastatic Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleDaiichi SankyoPhase 2

T-DXd (fam-trastuzumab deruxtecan-nxki, fam-trastuzumab deruxtecan-nxki (T-DXd))

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleHenan Cancer HospitalPhase 2

trastuzumab (Herceptin, fruquintinib＋trastuzumab + XELOX)

Gastric Adenocarcinoma; Gastric (Stomach) Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleGuangdong Provincial People's H…Phase 3

TCHP (investigator-selected taxane/carboplatin/trastuzumab/pertuzumab, investigator-selected taxane/carboplatin/trastuzumab/pertuzumab (TCHP))

Neoadjuvant Therapies for HER2+ Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

THP (investigator-selected taxane/trastuzumab/pertuzumab, investigator-selected taxane/trastuzumab/pertuzumab (THP))

Neoadjuvant Therapies for HER2+ Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystalePeking Union Medical College Ho…Phase 3

trastuzumab (Herceptin, lapatinib/herceptin)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE

12 / 13 페이지

← 이전다음 →